España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Irwin Naturals
IWINF
OTCPK
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.143760
-0.39
-73.26%
Last update: 9:31 AM
15 minutes delayed
Get Report
Comment
Irwin Naturals (IWINF) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Irwin Naturals (OTC:IWINF) Stock
Irwin Naturals Stock (OTC: IWINF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 05, 2023
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Lara Goldstein
Tuesday, November 28, 2023
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
Nina Zdinjak
Tuesday, September 05, 2023
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein
Monday, August 28, 2023
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Jelena Martinovic
Friday, August 25, 2023
Cannabis Stock Gainers And Losers From August 25, 2023
Benzinga Insights
Thursday, August 17, 2023
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Benzinga Insights
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
Friday, July 28, 2023
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
Vuk Zdinjak
Thursday, July 27, 2023
Cannabis Stock Movers For July 27, 2023
Benzinga Insights
Thursday, June 01, 2023
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
Vuk Zdinjak
Wednesday, May 31, 2023
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Lara Goldstein
Friday, May 26, 2023
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
Vuk Zdinjak
Monday, May 08, 2023
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
Lara Goldstein
Friday, May 05, 2023
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
Jelena Martinovic
Wednesday, May 03, 2023
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
Lara Goldstein
Monday, May 01, 2023
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
Vuk Zdinjak
Monday, March 27, 2023
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Lara Goldstein
Friday, March 24, 2023
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Vuk Zdinjak
Wednesday, March 22, 2023
Irwin Naturals Acquires Ketamine Media
Vuk Zdinjak
Monday, March 20, 2023
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Lara Goldstein
Thursday, March 16, 2023
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Lara Goldstein
Wednesday, March 15, 2023
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Lara Goldstein
Monday, March 06, 2023
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Lara Goldstein
Thursday, March 02, 2023
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Lara Goldstein
Tuesday, February 28, 2023
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Lara Goldstein
Tuesday, February 21, 2023
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Vuk Zdinjak
Monday, February 06, 2023
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Lara Goldstein
Friday, February 03, 2023
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Lara Goldstein
Thursday, February 02, 2023
Irwin Naturals Secures $40M To Accelerate Expansion Of Its Psychedelic Mental Health Clinics
Vuk Zdinjak
Friday, January 27, 2023
Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
Vuk Zdinjak
Thursday, January 26, 2023
Irwin Naturals TCH Products To Hit The Shelves Of ~2700 Dispensaries In Oklahoma Via Gold Rush
Vuk Zdinjak
Tuesday, January 24, 2023
Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth
Nicolás Jose Rodriguez
Monday, January 23, 2023
Cantor Fitzgerald Maintains Overweight on Irw...
Benzinga Newsdesk
Tuesday, January 10, 2023
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Lara Goldstein
Wednesday, December 21, 2022
Irwin Naturals To Enter Oregon Cannabis Market Via Hyphae Wellness
Vuk Zdinjak
Tuesday, December 13, 2022
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Lara Goldstein
Friday, December 09, 2022
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
Jelena Martinovic
Irwin Naturals Completes The Acquisition Of Three Mental Health Clinics
Vuk Zdinjak
Cantor Fitzgerald Maintains Overweight on Irw...
Benzinga Newsdesk
Tuesday, December 06, 2022
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein
Irwin Naturals Q3 Revenue Declines 7% YoY, What About Adjusted EBITDA?
Vuk Zdinjak
Wednesday, November 30, 2022
Irwin Naturals To Acquire Serenity Health
Vuk Zdinjak
Monday, November 07, 2022
Irwin Naturals THC Products To Be Available In Mississippi Cannabis Dispensaries
Vuk Zdinjak
Thursday, November 03, 2022
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Lara Goldstein
Tuesday, November 01, 2022
Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Lara Goldstein
Friday, October 07, 2022
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Lara Goldstein
Wednesday, October 05, 2022
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Lara Goldstein
Tuesday, October 04, 2022
This Nutraceutical Company Stands To Become Leader In A Projected $50B Industry, New Analyst Insights
Jelena Martinovic
Show More
